14800-DvRappard

56 Chapter 3 REFERENCES 1. van Rappard DF, Boelens JJ, Wolf NI. Metachromatic leukodystrophy: Disease spectrum and approaches for treatment. Best Pract Res Clin Endocrinol Metab . 2015;29:261-273. 2. GieselmannV, Krageloh-Mann I. Metachromatic leukodystrophy--an update. Neuropediatrics. 2010;41:1-6. 3. Hyde TM, Ziegler JC, Weinberger DR. Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. Arch Neurol. 1992;49:401-406. 4. Bayever E, Ladisch S, Philippart M, Brill N, Nuwer M, Sparkes RS, et al. Bone-marrow transplantation for metachromatic leucodystrophy. Lancet . 1985;2:471-473. 5. Boucher AA, Miller W, Shanley R, Ziegler R, Lund T, Raymond G, et al. Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report. Orphanet J Rare Dis . 2015;10:94-0313. 6. Jeffery R, Jeffery A. Metachromatic leukodystrophy: two sides of a coin. BMJ. 1993;307:1631- 1632. 7. Rivinus TM, Jamison DL, Graham PJ. Childhood organic neurological disease presenting as psychiatric disorder. Arch Dis Child . 1975;50:115-119. 8. Gordon N. The insidious presentation of the juvenile formof metachromatic leucodystrophy. Postgrad Med J . 1978;54:335-337. 9. Ahmed RM, Murphy E, Davagnanam I, Parton M, Schott JM, Mummery CJ, et al. A practical approach to diagnosing adult onset leukodystrophies. J Neurol Neurosurg Psychiatry. 2014;85:770-781.